Key facts
- Visa will acquire fraud intelligence provider BioCatch for $2.4 billion.
- The acquisition of BioCatch is an all-cash deal.
- Visa is expanding into fraud prevention technology with this acquisition.
- American Family Mutual Insurance Company will acquire Bowhead Specialty.
- The acquisition of Bowhead Specialty is an all-cash deal valued at approximately $1.2 billion.
- Bowhead stockholders will receive $34.00 per share.
- The offer for Bowhead Specialty represents an 11% premium to its July 31, 2026 closing price.
- The Bowhead Specialty acquisition is expected to close by the end of 2026.
Visa announced Monday its intention to acquire fraud intelligence provider BioCatch for $2.4 billion in an all-cash deal. This acquisition represents a significant move by Visa to expand its capabilities in fraud prevention technology. The transaction aims to enhance Visa's existing fraud detection and prevention services by integrating BioCatch's expertise and technology.
In a separate development, American Family Mutual Insurance Company has agreed to acquire Bowhead Specialty. This transaction is valued at approximately $1.2 billion and will be conducted as an all-cash deal. Shareholders of Bowhead Specialty are slated to receive $34.00 per share. This offer represents an 11% premium compared to the closing price of Bowhead Specialty stock on July 31, 2026. The acquisition is anticipated to be finalized by the end of 2026, subject to customary closing conditions.